Leaflet PRIMOVIST 0.25mmol/ml 181.43mg / ml solution for injection
Indicated for: diagnostic imaging contrast enhancement
Route of administration: injectable
Substance: gadoxetic acid (contrast agent)
ATC: V08CA10 (Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
This medicine may affect the kidneys.
Gadoxetic acid is a contrast agent used in magnetic resonance imaging (MRI), particularly for liver evaluation. It contains gadolinium, a metal that helps improve the clarity of MRI images.
It is commonly used for diagnosing liver lesions, including tumors or other hepatic conditions. Administration is done intravenously, and the substance is eliminated from the body through the kidneys and liver.
Side effects are rare but may include nausea, headaches, or allergic reactions. In patients with severe renal impairment, there is a very small risk of nephrogenic systemic fibrosis.
Patients should inform their doctor about any kidney or liver conditions before administration. The use of this contrast agent should be supervised by a specialist to minimize risks.
General data about PRIMOVIST 0.25mmol/ml 181.43mg / ml
- Substance: gadoxetic acid
- Date of latest medicines list: 01-03-2022
- Product code: W59234007
- Concentration: 181.43mg / ml
- Pharmaceutical form: solution for injection
- Quantity: 1
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for gadoxetic acid
Concentrations available for gadoxetic acid
- 181.430mg
- 181.43mg/ml